Beta‐blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

A preclinical study demonstrated anti‐proliferative and apoptotic effect of propranolol on multiple myeloma (MM) cell. Clinical studies suggested that beta‐blocker (BB) might impact the prognosis of breast, prostate, colorectal, ovarian, lung, and skin cancer. This retrospective study evaluated the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Hematol
Päätekijät: Hwa, Yi L., Shi, Qian, Kumar, Shaji K., Lacy, Martha Q., Gertz, Morie A., Kapoor, Prashant, Buadi, Francis K., Leung, Nelson, Dingli, David, Go, Ronald S., Hayman, Suzanne R., Gonsalves, Wilson I., Russell, Stephen, Lust, John A., Lin, Yi, Rajkumar, S. Vincent, Dispenzieri, Angela
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2016
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217079/
https://ncbi.nlm.nih.gov/pubmed/27733010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24582
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia